Consilient Health is pleased to announce that we have signed a long term, exclusive agreement with Angelini Farmaceutica S.A for them to launch and distribute Benferol® in the Spanish market.
“Spain is an extremely important territory for Benferol® “, commented Executive Vice Chairman Luke Crosbie. “We are delighted to be partnering with a company as well-respected and successful as Angelini and look forward to a successful launch in Spain later this year”.
Spain is a new territory for the Consilient Health portfolio and it further strengthens our geographic reach within Europe and the Middle East.
Code No: UK/CH/0519/0074
Date of Preparation: May 2019